Ticker
BDTXCompany Name
BLACK DIAMOND THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 129.81M | $ -45K | $ 0 | $ 0 | 0.03% |
3/31/2025 | $ 99.51M | $ 21.45M | $ 0 | $ 0 | -21.55% |
12/31/2024 | $ 107.66M | $ 25.55M | $ 0 | $ 0 | -23.73% |
9/30/2024 | $ 183.9M | $ 25.21M | $ 0 | $ 0 | -13.71% |
6/30/2024 | $ 282.81M | $ 97.39M | $ 0 | $ 0 | -34.44% |
3/31/2024 | $ 379.71M | $ 76.01M | $ 0 | $ 0 | -20.02% |
12/31/2023 | $ 195.49M | $ 71.93M | $ 0 | $ 0 | -36.8% |
9/30/2023 | $ 98.62M | $ 71.95M | $ 0 | $ 0 | -72.95% |
6/30/2023 | $ 171.75M | $ 75K | $ 0 | $ 0 | -0.04% |
3/31/2023 | $ 66.45M | $ 75K | $ 0 | $ 0 | -0.11% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for BLACK DIAMOND THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 214.11M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.22B ]
(=) Shareholder Yield [ -17.49% ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |